Tag: 2026
Wockhardt Launches “Wockhardt Antibiotic Academy” to Tackle Growing Threat of Multidrug Resistance in India
Wockhardt Limited announced the launch of the Wockhardt Antibiotic Academy, a national initiative dedicated to fostering patient-centric scientific dialogue and advancing continuous medical education to...
Optimus Pharma Secures Regulatory Approval for Non-Steroidal Tapinarof Cream to Treat Plaque Psoriasis
Optimus Pharma, a leading Indian pharmaceutical manufacturer and subsidiary of Sekhmet Pharmaventures, announced that it has received regulatory marketing approval for Tapinarof cream, an...
Argenx’s Efgartigimod Clears Phase 3, Bringing New Hope for Autoimmune Myositis
argenx SE (Euronext & Nasdaq: ARGX) reported on August 17 that its Phase 3 ALKIVIA trial of subcutaneous efgartigimod (marketed as VYVGART Hytrulo) achieved its primary goal in...
Pfizer-Valneva Lyme Vaccine Clears Key EU Regulatory Step
Pfizer Inc. and Valneva SE announced that the European Medicines Agency has formally accepted for review the Marketing Authorization Application for their jointly developed Lyme disease...
Telangana Government Merges Food Safety and Drugs Control Departments to Form Unified Authority ‘TG SAFE’
In a major regulatory and administrative reform, the Government of Telangana has merged the Food Safety Department and the Drugs Control Department into a...
Blue Jet Healthcare Inaugurates Advanced R&D Centre in Hyderabad to Accelerate Green Chemistry and Pharmaceutical Innovation
Blue Jet Healthcare Ltd, a prominent global contract development and manufacturing organization (CDMO), has officially inaugurated its state-of-the-art Research and Development (R&D) Centre in...
